Composition
- Active ingredients
- NAPROXEN 500MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NAPROXEN 25MG/ML · SuspensionANDA211910-001 · Prescription
- NAPROXEN 500MG · TabletANDA074121-003 · Discontinued
- NAPROXEN 250MG · TabletANDA074121-001 · Discontinued
- NAPROXEN 375MG · TabletANDA074121-002 · Discontinued
- NAPROXEN 500MG · TabletANDA074129-003 · Discontinued
- NAPROXEN 250MG · TabletANDA074129-001 · Discontinued
- NAPROXEN 375MG · TabletANDA074129-002 · Discontinued
- NAPROXEN 375MG · TabletANDA074163-002 · Discontinued
- NAPROXEN 500MG · TabletANDA074163-003 · Discontinued
- NAPROXEN 250MG · TabletANDA074163-001 · Discontinued
- NAPROXEN 25MG/ML · SuspensionANDA215776-001 · Prescription
- NAPROXEN 375MG · Tablet, delayed releaseANDA218497-001 · Prescription
- NAPROXEN 500MG · Tablet, delayed releaseANDA218497-002 · Prescription
- NAPROXEN 375MG · TabletANDA074211-002 · Discontinued
At a glance
- Brand name
- Naproxen
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Purepac Pharm
- Status
- Discontinued
- FDA approval
- 28 Sept 1993
- Application
- ANDA074263-003